Osteonecrosis of the jaw in patients with multiple myeloma treated with zoledronic acid

Journal of Bone and Mineral Metabolism

Volumn 27, Issue 4, 2009, Pages 435-443

  Cetiner, Sedat ^a   Sucak, Gulsan Turkoz ^a   Kahraman, Sevil Altundag ^a   AkI, Sahika Zeynep ^a   Kocakahyaoglu, Benay ^a   Gultekin, Sibel Elif ^a   Cetiner, Mustafa ^b   Haznedar, Rauf ^a  

^a GAZI UNIVERSITY   (Turkey)

^b MARMARA UNIVERSITY   (Turkey)

Author keywords

Bisphosphonates; Jaw osteonecrosis; Multiple myeloma; Thalidomide; Zoledronic acid

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CHLORHEXIDINE GLUCONATE; CLINDAMYCIN; DEXAMETHASONE; MELPHALAN; THALIDOMIDE; ZOLEDRONIC ACID;

ACTINOBACTERIA; ADULT; AGED; ALVEOLAR BONE; ANTIBIOTIC PROPHYLAXIS; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE RESECTION; CLINICAL ARTICLE; CLINICAL EVALUATION; CONSERVATIVE TREATMENT; DEBRIDEMENT; DRUG MEGADOSE; ERYTHEMA; FEMALE; GRANULATION TISSUE; HEALING IMPAIRMENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; JAW OSTEONECROSIS; MALE; MANDIBLE; MAXILLA; MORBIDITY; MOUTH EXAMINATION; MOUTH HYGIENE; MOUTH MUCOSA; MOUTH PAIN; MULTIPLE MYELOMA; ORAL BLEEDING; PRIORITY JOURNAL; RISK FACTOR; SUPPURATION; SWELLING; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; TREATMENT DURATION; WOUND CARE;

ADULT; AGED; BONE DENSITY CONSERVATION AGENTS; BONE RESORPTION; DEXAMETHASONE; DIPHOSPHONATES; FEMALE; HUMANS; IMIDAZOLES; JAW; MALE; MIDDLE AGED; MULTIPLE MYELOMA; NECROSIS; OSTEOCLASTS; OSTEONECROSIS; THALIDOMIDE;

EID: 67749103911     PISSN: 09148779     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00774-009-0047-9     Document Type: Article

References (37)

1. CR Dunstan D Felsenberg MJ Seibel 2007 Therapy insight: the risks and benefits of bisphosphonates for the treatment of tumor-induced bone disease Nat Clin Pract Oncol 4 42 55 (Pubitemid 46017693)
2. MD Melo G Obeid 2005 Osteonecrosis of the maxilla in a patient with a history of bisphosphonate therapy J Can Dent Assoc 71 111 113
3. NA Robinson JF Yeo 2004 Bisphosphonates-a word of caution Ann Acad Med Singap 33 48 49
4. R Diego O D'Orto D Pagani A Agazzi U Marzano G Derada Troletti W Fontanella L Pignataro 2007 Bisphosphonate-associated osteonecrosis of the jaws-a therapeutic dilemma Oral Surg Oral Med Oral Pathol Oral Radiol Endod 103 e1 e5
5. SL Ruggiero B Mehrotra TJ Rosenberg SL Engroff 2004 Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases J Oral Maxillofac Surg 62 527 534 (Pubitemid 38542516)
6. DE Hughes BR MacDonald RG Russell M Gowen 1989 Inhibition of osteoclast-like cell formation by bisphosphonates in long-term cultures of human bone marrow J Clin Invest 83 1930 1935 (Pubitemid 19148862)
7. MJ Rogers S Gordon HL Benford FP Coxon SP Luckman J Monkkonen JC Frith 2000 Cellular and molecular mechanisms of action of bisphosphonates Cancer 15 88 2961 2978 (Pubitemid 30413179)
8. DE Hughes KR Wright HL Uy A Sasaki T Yoneda GD Roodman GR Mundy BF Boyce 1995 Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo J Bone Miner Res 10 1478 1487
9. RE Marx 2003 Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic J Oral Maxillofac Surg 61 1115 1117 (Pubitemid 37064711)
10. K Zervas E Verrou Z Teleioudis K Vahysevanos A Banti D Mihou D Krikelis E Terpos 2006 Incidence, risk factors and management of osteonecrosis of the jaw in patients with multiple myeloma: a single-centre experience in 303 patients Br J Haematol 134 620 623 (Pubitemid 44253605)
11. Prophet EB, Mills B, Arrington JB, Sobin LH (1992) Laboratory methods in histotechnology. Armed Forces Institute of Pathology. AM Registry of Pathology Washington DC
12. JV Bagan J Murillo Y Jimenez R Poveda MA Milian JM Sanchis FJ Silvestre C Scully 2005 Avascular jaw osteonecrosis in association with cancer chemotherapy: series of 10 cases J Oral Pathol Med 34 120 123
13. MD Melo G Obeid 2005 Osteonecrosis of the jaws in patients with a history of receiving bisphosphonate therapy: strategies for prevention and early recognition J Am Dent Assoc 136 1675 1681 (Pubitemid 41810029)
14. MA Pogrel CE Miller 2003 A case of maxillary necrosis J Oral Maxillofac Surg 61 489 493 (Pubitemid 36396980)
15. T Reuther T Schuster U Mende A Kubler 2003 Osteoradionecrosis of the jaws as a side effect of radiotherapy of head and neck tumour patients-a report of a thirty year retrospective review Int J Oral Maxillofac Surg 32 289 295 (Pubitemid 36700738)
16. SL Ruggiero J Fantasia E Carlson 2006 Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management Oral Surg Oral Med Oral Pathol Oral Radiol Endod 102 433 441 (Pubitemid 44403162)
17. AM Vannucchi G Ficarra E Antonioli A Bosi 2005 Osteonecrosis of the jaw associated with zoledronate therapy in a patient with multiple myeloma Br J Haematol 128 738 (Pubitemid 40444865)
18. T Hansen M Kunkel A Weber CJ Kirkpatrick 2006 Osteonecrosis of the jaws in patients treated with bisphosphonates-histomorphologic analysis in comparison with infected osteoradionecrosis J Oral Pathol Med 35 155 160
19. T Hansen M Kunkel E Springer C Walter A Weber E Siegel CJ Kirkpatrick 2007 Actinomycosis of the jaws-histopathological study of 45 patients shows significant involvement in bisphosphonate-associated osteonecrosis and infected osteoradionecrosis Virchows Arch 451 1009 1017 (Pubitemid 350165265)
20. R Font Gomez MLM Garcia JMO Martinez 2008 Osteochemonecrosis of the jaws due to bisphosphonate treatments. Update Med Oral Patol Oral Cir Bucal 13 318 324
21. J Sarin SS DeRossi SO Akintoye 2008 Updates on bisphosphonates and potential pathobiology of bisphosphonate-induced jaw osteonecrosis Oral Dis 14 277 285
22. SB Woo JW Hellstein JR Kalmar 2006 Narrative review: bisphosphonates and osteonecrosis of the jaws Ann Intern Med 144 753 761 (Pubitemid 46780635)
23. M Ardine D Generali M Donadio 2006 Could the long-term persistence of low serum calcium levels and high serum parathyroid hormone levels during bisphosphonate treatment predispose metastatic breast cancer patients to undergo osteonecrosis of the jaw? Ann Oncol 17 1336 1337 (Pubitemid 44288231)
24. K Suda N Udugawa N Sato 2004 Suppression of osteoprotegrin expression by prostaglandin E2 crucially involved in lipopolysaccharide-induced osteoclast formation J Immunol 172 2504 2508
25. EC Li LE Davis 2003 Zoledronic acid: a new parenteral bisphosphonate Clin Ther 25 2669 2708 (Pubitemid 37510584)
26. BG Durie M Katz J Crowley 2005 Osteonecrosis of the jaw and bisphosphonates N Engl J Med 353 99 102
27. AO Hoff BB Toth K Altundag MM Johnson CL Warneke M Hu A Nooka G Sayegh V Guarneri K Desrouleaux J Cui A Adamus RF Gagel GN Hortobagyi 2008 Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates J Bone Miner Res 23 826 836 (Pubitemid 351768801)
28. C Van Poznak C Estilo 2006 Osteonecrosis of the jaw in cancer patients receiving IV bisphosphonates Oncology (Williston Park) 20 1053 1065
29. A Bamias E Kastritis C Bamia LA Moulopoulos I Melakopoulos G Bozas V Koutsoukou D Gika A Anagnostopoulos C Papadimitriou E Terpos MA Dimopoulos 2005 Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors J Clin Oncol 23 8580 8587 (Pubitemid 46211499)
30. TM Moehler J Hillengass A Glasmacher H Goldschmidt 2006 Thalidomide in multiple myeloma Curr Pharm Biotechnol 7 431 440 (Pubitemid 46017534)
31. P Tosi E Zamagni D Cangini P Tacchetti F Di Raimondo L Catalano A D'Arco S Ronconi C Cellini M Offidani G Perrone M Ceccolini A Brioli S Tura M Baccarani M Cavo 2006 Osteonecrosis of the jaws in newly diagnosed multiple myeloma patients treated with zoledronic acid and thalidomide-dexamethasone Blood 108 3951 3952 (Pubitemid 44864588)
32. RE Marx Y Sawatari M Fortin V Broumand 2005 Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention and treatment J Oral Maxillofac Surg 63 1567 1575 (Pubitemid 41525412)
33. A Woeller A Gering M Brix G Bettega J Lebeau 2006 Bone necrosis of the jaws in five patients taking bisphosphonates Rev Stomatol Chir Maxillofac 107 417 422
34. MC Farrugia DJ Summerlin E Krowiak T Huntley S Freeman R Borrowdale C Tomich 2006 Osteonecrosis of the mandible or maxilla associated with the use of new generation bisphosphonates Laryngoscope 116 115 120 (Pubitemid 44383974)
35. American Dental Association Council on Scientific Affairs 2006 Dental management of patients receiving oral bisphosphonate therapy: expert panel recommendations J Am Dent Assoc 137 1144 1150
36. H Katz 2005 Endodontic implications of bisphosphonate-associated osteonecrosis of the jaws: a report of three cases J Endod 31 831 834 (Pubitemid 41578797)
37. MM Curi GS Cossolin DH Koga SR Araujo O Feher MO Dos Santos C Zardetto 2007 Treatment of avascular osteonecrosis of the mandible in cancer patients with a history of bisphosphonate therapy by combining bone resection and autologous platelet-rich plasma: report of 3 cases J Oral Maxillofac Surg 65 349 355 (Pubitemid 46131421)